Mirae Asset Global Investments Co., Ltd. Enveric Biosciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$8.8 - $16.2 $2.52 Million - $4.64 Million	-286,267 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$12.5 - $52.0 $1.33 Million - $5.55 Million	-106,653 Reduced 27.14%	286,267 $94,000
Q4 2021 Feb 08, 2022	BUY	$46.5 - $104.0 $18.3 Million - $40.9 Million	392,920 New	392,920 $365,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.